Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2017

Dec 12, 2017

35086_dirs_2017-12-12_04fb851b-f91b-477a-b646-1e259f6dec20.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-12-11

Reporting Person: Russell Richard E. (President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-11 Common Stock A 40000 $0.00 Acquired 40000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-11 Employee Stock option (Right to Buy) $6.05 A 775000 Acquired 2027-12-10 Common Stock (775000) Direct

Footnotes

F1: Represents shares of the Issuer's Common Stock underlying a time-based restricted stock unit award ("RSU"). The shares subject to this RSU will vest in four (4) equal annual installments commencing on the one-year anniversary of December 11, 2017, provided the Reporting Person has provided continuous service to the Issuer through the vesting date.

F2: This option vested as to 25% of the shares on December 11, 2018 and then in quarterly installments over 3 years thereafter.